Wednesday, March 11, 2026 9:15:55 AM
KALA Bio just announced a major pivot into AI for biotech.
The company launched Researgency.ai, a platform designed to deploy AI agents for pharmaceutical & biotech workflows, with the first commercial AI agent expected within ~14 days.
https://finance.yahoo.com/news/kala-bio-launches-revolution-biotech-103000840.html
🧠 Key highlights:
• AI platform Researgency.ai now live
• First biotech AI agent shipping in ~14 days
• Targeting the $180B AI healthcare market
• Positioning itself as the “Palantir for biotech”
The platform aims to automate research, clinical, regulatory, and commercial tasks for biotech companies using purpose-built AI agents.
👀 Traders watching this AI + biotech pivot closely.
#stocks #biotech #AI #stockmarket
Recent KALA News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/17/2026 08:59:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:04:20 PM
- KALA BIO plans to release first commercial AI agent within two weeks • IH Market News • 03/11/2026 03:22:00 PM
- Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents • Newsfile • 03/11/2026 03:18:00 PM
- Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates • GlobeNewswire Inc. • 03/11/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 02:16:52 PM
- KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform “Researgen • GlobeNewswire Inc. • 03/04/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:05:55 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/17/2026 09:44:14 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:16:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:16:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 11:01:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/26/2026 09:05:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 09:05:28 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/13/2026 01:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 09:07:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/08/2026 09:05:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/06/2026 09:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 12:30:47 PM
- KALA BIO Settles Approximately $10.6 million of Debt • GlobeNewswire Inc. • 01/05/2026 09:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:15:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/30/2025 09:12:48 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
